U.S. General Merchandise and Department Stores Stock News

Adams Diversified Equity Fund has delivered a strong 122.1% total return over the past 5 years, yet current valuation checks and market multiples still point to the stock as screening on the cheaper side rather than obviously priced for perfection. A 122.1% return over 5 years suggests that long term holders in Adams Diversified Equity Fund have already seen substantial value created, which raises the bar for any further upside to be justified by fundamentals. Recent coverage highlighting...

Mastercard stock sits at an interesting point, with a roughly 48.7% total return over the past five years and a recent share price of US$551.54, while the broader valuation checks still lean toward the shares being expensive rather than a clear bargain. Over five years, Mastercard has returned about 48.7%, which is a solid outcome but not one that automatically justifies paying any price for the stock. On the upside, ongoing growth in digital payments and partnerships across areas like cross...

Viking Holdings (VIK) has drawn attention after announcing two 2030 river itineraries built around preferred access to the once a decade Oberammergau Passion Play, paired with a broad Summer Sale promotion. See our latest analysis for Viking Holdings. The latest Oberammergau focused itineraries and Summer Sale come as Viking Holdings trades at US$98.07, with a year to date share price return of 35.7% and a 1 year total shareholder return of 70.73%. This suggests momentum has been strong even...

Political tensions around election integrity, foreign interference and the Save America Act are pulling security and trust in US institutions back into the spotlight. For investors, that mix of uncertainty and policy focus can redirect attention toward companies linked to national defense, cybersecurity and critical infrastructure, especially where election security is a core concern. This article looks at how that news backdrop connects to our US Defense and Cybersecurity Stocks screener. It...

J.B. Hunt Transport Services (JBHT) has reported Q2 2026 revenue of US$3.5 billion and basic EPS of US$1.91, against a backdrop where earnings over the last year are reported to have grown 21.8%. The company’s quarterly revenue has increased from US$2,928.2 million and EPS of US$1.32 in Q2 2025 to US$3,495.3 million and EPS of US$1.91 in Q2 2026. Over the same period, trailing net margin has moved up to 5.3% from 4.6% in the prior year. These shifts may encourage investors to examine how the...

Nasdaq (NDAQ) is drawing fresh attention as investors position ahead of its July 23 earnings report, with expectations for higher quarterly earnings and revenue, while mixed sentiment creates uncertainty around a potential beat or miss. See our latest analysis for Nasdaq. At a share price of $94.25, Nasdaq has seen a 7.69% 7 day share price return and a 6.37% 90 day share price return. The 1 year total shareholder return of 6.10% sits against a softer year to date share price return that is...

After a mixed few years for shareholders, TransMedics Group stock now sits at around US$76 with a 5 year return of roughly 154%, and the current valuation checks suggest that, despite recent share price pressure, the stock still leans toward the cheaper side of the spectrum. Over 5 years, TransMedics Group has returned about 153.6%, which puts the recent 1 year and year to date share price declines in the context of a much stronger longer term run. The recent investment in Germany based PAD...

Teekay Tankers (TNK) has been in focus after analysts highlighted the stock as a value play, pointing to valuation ratios and an earnings outlook that has attracted renewed attention from value-oriented investors. See our latest analysis for Teekay Tankers. Teekay Tankers' recent move to US$71.83 comes after a 7 day share price return of about 3.7% and a year to date share price return of roughly 39.5%. The 1 year total shareholder return of about 64.9% and very large 5 year total shareholder...

Clarivate (CLVT) has been selected by France’s Bibliographic Agency for Higher Education, Abes, to modernize the national academic library system covering more than 15 million records across 3,000 libraries, while management reaffirmed full year revenue guidance. See our latest analysis for Clarivate. Clarivate’s recent Abes win and its support for the U.S. Patent and Trademark Office’s AI assisted image search come as the stock shows short term momentum, with a 1 month share price return of...

Union Pacific stock has delivered a 52.7% return over the past five years, and at around US$299 per share the valuation signals are now more finely balanced, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares are roughly in line with fair value while earnings based multiples still screen as attractive. Over the last 5 years, a 52.7% return suggests Union Pacific has already rewarded long term holders. Fresh buyers need to think carefully about how much upside...

Quest Diagnostics Incorporated recently integrated its Haystack MRD ctDNA test and Comprehensive Genomic Profiling services for solid tumors into Flatiron Health’s OncoEMR via a pilot with American Oncology Network and other community providers, giving 4,700 clinicians at 1,600 U.S. cancer care locations easier access to these tests within their existing electronic health record workflows. This move makes Quest the largest clinical reference lab to plug advanced oncology testing directly...

With inflation signals mixed across major economies, rate paths uncertain and trade policies in flux, many investors are looking for companies where insiders are strongly aligned with shareholders and where external expectations remain optimistic. The Fast Growing Stocks With High Insider Ownership screener focuses exactly on that combination, highlighting businesses where growth prospects are supported by both analyst and management outlooks. In this article, you will see three stocks from...

HCI Group’s board has declared a regular quarterly cash dividend of US$0.40 per common share, payable on September 18, 2026, to shareholders of record as of August 21, 2026. This reaffirmed payout, alongside strong growth in premiums, earnings and book value per share, underscores management’s confidence in the insurer’s financial position. With the dividend reaffirmed, we’ll examine how this income commitment and recent analyst upgrades affect HCI Group’s evolving investment narrative. The...

XP (NasdaqGS:XP) is drawing fresh attention after XP Investimentos reported that over 99% of corporate spend now flows through an integrated, AI supported procurement platform. The shift is aimed at tighter cost control and supplier risk management. See our latest analysis for XP. XP's recent AI procurement update comes as the stock trades at US$16.68, with a 30 day share price return of 6.38%, a 90 day share price decline of 20.95%, and a 1 year total shareholder return decline of 5.82%...

Danaher stock sits in an unusual valuation spot right now, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a meaningful discount, while earnings-based multiples lean the other way and flag the shares as expensive. Over the past 5 years, Danaher shares have declined 18%, which means long-term holders have not yet seen a clear payoff from staying invested. Recent news around Leica Biosystems’ planned acquisition of StatLab and new Alzheimer’s testing capabilities at...

Hasbro, ticker NasdaqGS:HAS, and Nintendo have agreed a multi year licensing partnership to produce The Legend of Zelda toys. The toy line is scheduled to launch in 2027 alongside the planned live action The Legend of Zelda film. The agreement extends Hasbro's relationship with Nintendo beyond existing franchises and adds a new entertainment linked product range. Hasbro has been building out its position in branded toys, games and collectibles, and this new Zelda partnership is part of...

Boeing stock has slipped about 7.2% over the past year, yet the valuation signals are split, with a Discounted Cash Flow (DCF) estimate pointing to meaningful upside while market multiples suggest the shares are not cheap. Boeing's share price is down 7.2% over the past year, which puts more focus on whether the current level already reflects its operational and regulatory challenges. Progress on 737 MAX certifications and production ramp ups can support future cash flow expectations, while...

Alibaba Group Holding (NYSE:BABA) has been in focus after Chinese regulators approved Apple Intelligence for use in China, pairing Apple’s on device AI services with Alibaba’s Qwen models across multiple Apple platforms. See our latest analysis for Alibaba Group Holding. Recent moves in Alibaba Group Holding’s share price reflect that traders are reacting strongly to AI and regulatory headlines, with a 7 day share price return of 5.71% and a 1 year total shareholder return of 1.06%...

EchoStar stock has delivered a very strong 378.5% return over the past three years, yet its valuation checks currently send mixed signals as the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside while market multiples lean the other way. Over three years, EchoStar has returned 378.5%. This makes the current pricing question more about how much of the story is already reflected in the share price. Recent analyst focus on the potential value of EchoStar's SpaceX...

Why Genworth Financial’s Leadership Change Matters for Shareholders Genworth Financial (GNW) recently announced that long-time President and CEO Tom McInerney is taking a temporary health-related leave of absence, with Chief Financial Officer Jerome Upton appointed as Interim President and CEO. For you as an investor, this type of leadership shift can influence how the market thinks about Genworth Financial’s future priorities, risk profile, and capital allocation. This is particularly...

Pfizer (PFE) is back in focus after the U.S. Food and Drug Administration approved PADCEV plus Keytruda as a platinum free neoadjuvant and adjuvant regimen for adult patients with muscle invasive bladder cancer. See our latest analysis for Pfizer. The latest FDA approval lands as Pfizer’s share price has been under pressure over longer periods, with a 90 day share price return that declined 8.78% but a 1 year total shareholder return of 9.43%. This suggests momentum is trying to rebuild from...

Bath & Body Works (BBWI) has just entered Brazil with its first store and a new digital destination in São Paulo, giving investors fresh context for thinking about the stock’s international growth ambitions. See our latest analysis for Bath & Body Works. For context, Bath & Body Works shares trade at US$21.12, with recent momentum skewing short term. The 1-day share price return is 2.23%, the 7-day return is 5.97% and the 90-day return is 8.81%, while the 1-year total shareholder return has...

SharonAI Holdings has delivered a very large 1 year return, yet its valuation checks and current market multiples point to a stock that leans expensive rather than clearly cheap. Over the last 12 months, SharonAI Holdings has returned about 7.7x, which puts extra pressure on today’s price to be backed by durable cash flow and earnings quality. Expectations that the company can translate its business model into consistent, scalable cash generation may support the current share price. However,...

Tempus AI recently highlighted results from the Articulate Pro study in Nature Digital Medicine, showing that the Paige Prostate Suite AI improved diagnostic consistency, sped up prostate biopsy reporting, and reduced laboratory workloads within the UK National Health Service. An important insight from the study is that AI-assisted review led to diagnosis or Grade Group updates in 5% of cases, with 1.3% potentially altering clinical management, underscoring how AI can meaningfully influence...